Direct fluorometric measurement of hepatitis C virus helicase activity

被引:42
作者
Boguszewska-Chachulska, AM
Krawczyk, M
Stankiewicz, A
Gozdek, A
Haenni, AL
Strokovskaya, L
机构
[1] PAS, Inst Biochem & Biophys, PL-02106 Warsaw, Poland
[2] Inst Jacques Monod, F-75251 Paris 05, France
[3] NAS, Inst Mol Biol & Genet Ukr, UA-03147 Kiev, Ukraine
关键词
hepatitis C virus; NS3; helicase; fluorometric assay;
D O I
10.1016/j.febslet.2004.04.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The non-structural protein 3 (NS3) of hepatitis C virus (HCV) is a highly promising target for anti-HCV therapy because of its multiple enzymatic activities, such as RNA-stimulated nucleoside triphosphatase, RNA helicase and serine protease. The helicase domain of NS3 as well as domain 2 of the helicase were expressed in a baculovirus system to obtain in high yield active proteins for prospective studies of complexes of the helicase with its inhibitors. A novel direct fluorometric test of helicase activity with a quenched DNA substrate, 3' labeled with a Cy3 dye and 5' labeled with a Black Hole Quencher, was developed and optimal reaction conditions established. This test based on fluorescence resonance energy transfer is simple and fast. It allows for direct measurements of enzyme activity, circumventing laborious and complicated radioactive techniques that are poorly reproducible. The results obtained encourage us to propose this new fluorescent assay as a method enabling high throughput screening of anti-helicase compounds. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 34 条
  • [1] In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep
    Acosta-Rivero, N
    Alvarez-Obregón, JC
    Musacchio, A
    Falcón, V
    Dueñas-Carrera, S
    Marante, J
    Menéndez, I
    Morales, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (01) : 300 - 304
  • [2] A novel high throughput screening assay for HCVNS3 helicase activity
    Alaoui-Ismaili, MH
    Gervais, C
    Brunette, S
    Gouin, G
    Hamel, M
    Rando, RF
    Bedard, J
    [J]. ANTIVIRAL RESEARCH, 2000, 46 (03) : 181 - 193
  • [3] Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies
    Artsaenko, O
    Tessmann, K
    Sack, M
    Häussinger, D
    Heintges, T
    [J]. JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 2323 - 2332
  • [4] BLACK ME, 1992, J BIOL CHEM, V267, P6801
  • [5] Molecular viral oncology of hepatocellular carcinoma
    Block, TM
    Mehta, AS
    Fimmel, CJ
    Jordan, R
    [J]. ONCOGENE, 2003, 22 (33) : 5093 - 5107
  • [6] Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses
    Borowski, P
    Deinert, J
    Schalinski, S
    Bretner, M
    Ginalski, K
    Kulikowski, T
    Shugar, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (08): : 1645 - 1653
  • [7] Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: Evidence for dissociation of the NTPase and helicase activities of the enzyme
    Borowski, P
    Niebuhr, A
    Mueller, O
    Bretner, M
    Felczak, K
    Kulikowski, T
    Schmitz, H
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (07) : 3220 - 3229
  • [8] Borowski P, 2001, ACTA BIOCHIM POL, V48, P739
  • [9] Biochemical properties of a minimal functional domain with ATP-binding activity of the NTPase/helicase of hepatitis C virus
    Borowski, P
    Kuehl, R
    Mueller, O
    Hwang, LH
    zur Wiesch, JS
    Schmitz, H
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03): : 715 - 723
  • [10] Subcellular localization and topology of the p7 polypeptide of hepatitis C virus
    Carrère-Kremer, S
    Montpellier-Pala, C
    Cocquerel, L
    Wychowski, C
    Penin, F
    Dubuisson, J
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (08) : 3720 - 3730